You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
振東製藥(300158.SZ)與神威大藥房達成戰略合作
格隆匯 05-27 07:50

格隆匯5月27日丨振東製藥(300158.SZ)宣佈,5月25日,公司作為甲方與河北神威大藥房連鎖有限公司(簡稱“神威大藥房”)作為乙方就業務合作簽訂了《戰略合作協議》。神威大藥房總部位於石家莊,所轄門店960家,2020年銷售額18億元,是中國醫藥零售企業前三十強企業,以誠信、實力獲得業界認可。

雙方具體合作如下:

1、全品種合作:雙方開展全產品合作,豐富各系列產品線,共同增加產品和品類影響力。甲方維生素礦物質類、心腦血管系列、消化領域等產品逐步全面導入;

2、現品種上量:確保現有品種在乙方的銷售增量;

3、終端品牌展示:雙方商討方案,甲方確保合作產品給予乙方最優惠合作條件,乙方確保產品的最優推薦等級和陳列位置;

4、統一價格政策:乙方執行甲方建議的統一零售價格,以及其它供貨政策;

5、共同維價:共同維護產品線上線下價格環境。

公司表示,雙方利用各自優勢,還將在品牌共建、資源共享方面展開戰略合作,通過該次合作,雙方品牌相互驅動,相互促進,為更多消費者提供更好的產品和服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account